SAVEX ONT .63 % — DIN 01966472
CAMPHOR : .63 % MENTHOL : .33 % · SABEX INC · OINTMENT · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is SAVEX ONT?
SAVEX ONT .63 % contains CAMPHOR : .63 % MENTHOL : .33 %. It is listed in the Health Canada Drug Product Database under DIN 01966472, held by SABEX INC, supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 02-Aug-2001. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Other Emollients And Protectives in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
30 holders have a Canadian DIN containing Other Emollients And Protectives, across 35 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BEAUTICONTROL INC. | 3 | 0 | BEAUTICONTROL BALANCING MOISTURIZER EML 0.6%, HAND THERAPY CREME, SKIN STRATEGIES FOR MEN-SOOTHING MOISTURIZER | No marketed DIN |
| BLISTEX CORPORATION | 2 | 0 | LIP CONDITIONER LIP BALM, MEDICATED BLISTEX DCT LIP BALM | No marketed DIN |
| BRISTOL-MYERS SQUIBB CANADA | 2 | 0 | KERI FAST ABSORBING - AHA - LOT 5%, KERI ORIGINAL - AHA - LOTION 5% | No marketed DIN |
| EVEREST PHARMACEUTICALS LTD. | 2 | 0 | VITAMIN E 30UNIT ONT NATURAL, VITAMIN E ONT | No marketed DIN |
| ACME UNITED CORPORATION | 1 | 0 | ONE TIME COMPOUND BENZOIN TCT F466 | No marketed DIN |
| ALBI NATURALS | 1 | 0 | VITAMIN E ONT 1000UNIT | No marketed DIN |
| CHESEBROUGH-POND'S CANADA | 1 | 0 | VASELINE BRAND LIP THERAPY MEDICATED TUBE | No marketed DIN |
| CONGLOM INC. | 1 | 0 | STYPTIC PENCIL STICK 42.0% | No marketed DIN |
| DRUG TRADING COMPANY LTD. | 1 | 0 | LANOLIN | No marketed DIN |
| DUCHESNAY INC | 1 | 0 | LE STICK A LEVRES ONYBEL | No marketed DIN |
| GALDERMA CANADA INC | 1 | 0 | WIBI LOTION 23% | No marketed DIN |
| JAMIESON LABORATORIES LTD | 1 | 0 | SOOTHEX - CRM TOP 1% | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | .63 % |
|---|---|
| Dosage form | OINTMENT |
| Route | TOPICAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Other Emollients And Protectives |
|---|---|
| ATC code | D02AX |
| AHFS class | 84:24.12 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01966472 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1966472 |
| Brand name | SAVEX ONT |
| Generic / active ingredient | CAMPHOR : .63 % MENTHOL : .33 % |
| Market authorization holder | SABEX INC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D02AX |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D02AX |
| Current status | CANCELLED POST MARKET |
| Status date | 02-Aug-2001 |
| Original market date | 1992-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 35 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AU KAH CHUEN SKIN LOTION | 1 % | LOTION | WING QUON ENTERPRISES LTD. | CANCELLED PRE MARKET | 02230428 |
| BANANA BOAT MEDICATED LIP BALM | 0.6 % | STICK | THE BANANA BOAT COMPANY | CANCELLED POST MARKET | 02229663 |
| BEAUTICONTROL BALANCING MOISTURIZER EML 0.6% | 0.6 % | EMULSION | BEAUTICONTROL INC. | CANCELLED POST MARKET | 02058987 |
| COLD SORE LOTION | 4 % | LOTION | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | 00558559 |
| ELTA DERMAL WOUND CLEANSER | 2 % | LOTION | SWISS AMERICAN PRODUCTS INC. | CANCELLED PRE MARKET | 02231349 |
| EXOREX ACNE FORMULA | 0.5 % | LOTION | MEYER ZALL LABORATORIES PTY LTD. | CANCELLED PRE MARKET | 02238344 |
| GLYCERIN LIQ 100% | 100 % | LIQUID | JEDMON PRODUCTS LTD. | CANCELLED POST MARKET | 00825662 |
| GLYCERIN USP (LIQUID) | 100 % | LIQUID | KOLMAR CANADA INC. | CANCELLED POST MARKET | 00892076 |
| HAND THERAPY CREME | 28 % | CREAM | BEAUTICONTROL INC. | CANCELLED POST MARKET | 02246586 |
| HEALING OINTMENT WITH VITAMIN E | 34 UNIT | OINTMENT | NUTRISTAR HEALTH PRODUCTS (1987) INC. | CANCELLED POST MARKET | 00584037 |
2 · Same class — other molecules in ATC D02AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Other Emollients And Protectives | AU KAH CHUEN SKIN LOTION · BANANA BOAT MEDICATED LIP BALM · BEAUTICONTROL BALANCING MOISTURIZER EML 0.6% · COLD SORE LOTION · +31 more | 35 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D02AC | Soft Paraffin And Fat Products | 111 | 15 |
| D02AA | Silicone Products | 41 | 7 |
| D02AB | Zinc Products | 94 | 5 |
| D02AD | Liquid Plasters | 2 | 0 |
| D02AE | Carbamide · Carbamide, Combinations | 13 | 0 |
| D02AF | Salicylic Acid Preparations | 160 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.